Latest filing published 06 Feb 2008 for BlackRock Health Sciences Trust, €9,383.
No signal scores available.
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kent Dixon is a declared insider at 12 companies; the most frequent names are Blackrock Dividend Achievers Trust, BlackRock Enhanced Global Dividend Trust and Blackrock Credit Allocation Income Trust. We count 25 filings; the first trade dates from 7 December 2005 and the latest from 6 February 2008.
The open-market record is one-sided, with 25 purchases worth €243k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2008 alone, the filings show 6 purchases and no sales.
In size, the median ticket on the buying side is €6,997. Looking at 12 purchases old enough to measure, the stock rose over the following 90 days in 42% of cases; the median change was -1.2%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 6 February 2008: an open-market purchase of €9,383, in BlackRock Health Sciences Trust. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations